Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 2626 AL 2640

Precision Health Optimization Program in the Management of Advanced Parkinson's Disease: A Case Series

Niraj G, Charan N, Niraj S, Karanth VB, Prakash L.

Cureus. 2026 Jan 9;18(1):e101146. doi: 10.7759/cureus.101146. eCollection 2026 Jan.

Lorazepam-induced full resolution of catatonia and psychosis in Parkinson's disease with acromegaly: a case report

Alnafisi A, Alharbi G, Ahmad R, Radi S, Alhubayshi M, AlGhamdi A.

Front Psychiatry. 2026 May 4;17:1806346. doi: 10.3389/fpsyt.2026.1806346. eCollection 2026.

From Stress to Neurodegeneration: A New Look at the Pathogenesis of Parkinson's Disease

Kazanskaya RB, Tsytsarev V, Volnova AB, Gainetdinov RR, Lopachev AV.

Biomedicines. 2026 May 16;14(5):1130. doi: 10.3390/biomedicines14051130.

Adiponectin in neuroinflammation and parkinson's disease: A macromolecular and therapeutic perspective

Chauhan K, Porwal M, Singh S.

Metab Brain Dis. 2026 Feb 28;41(1):42. doi: 10.1007/s11011-025-01769-6.

Alpha-Synuclein in Neurodegeneration: From Shared Biology to Disease-Specific Phenotypes

Su F, Kim WS, Halliday GM, Fu Y.

Cells. 2026 Mar 3;15(5):451. doi: 10.3390/cells15050451.

The recent research progress on traditional Chinese medicine application in Parkinson's disease: a review

Feng Q, Feng Y, Li D, Wang Y, Chen F, Cheng B, Yang J.

Front Aging Neurosci. 2026 Apr 29;18:1798695. doi: 10.3389/fnagi.2026.1798695. eCollection 2026.

Posterior Reversible Encephalopathy Syndrome (PRES) in an Elderly Patient With Advanced Parkinson's Disease and Autonomic Dysfunction: A Case Report and Literature Review

Abdelradi MU, Al Harbi A, Alsuhaibani E, Amir T, Yasser A.

Cureus. 2026 Mar 8;18(3):e104879. doi: 10.7759/cureus.104879. eCollection 2026 Mar.

[A "prion mechanism" involved in the progression of Parkinson's disease: towards innovative therapeutic approaches?]

Baron T.

Med Sci (Paris). 2026 Apr;42(4):385-388. doi: 10.1051/medsci/2026058. Epub 2026 Apr 24.

[Basal ganglia and movement disorders-Part 2: … and if it is not Parkinson's disease? : Nondegenerative causes and neuroradiological patterns]

Garner M.

Radiologie (Heidelb). 2026 Apr;66(4):295-303. doi: 10.1007/s00117-026-01591-w. Epub 2026 Mar 16.

Comparative Analysis of the Effect of Uridine on Oxidative and Energy Metabolism in the Blood during Administration of Rotenone and 6-Hydroxydopamine in Rats

Khunderyakova NV, Polyakova TV, Medvedeva VP, Bulgin IV, Malkov AE, Mironov VV, Khmil NV, Medentsev AG, Mironova GD.

Bull Exp Biol Med. 2026 Jan;180(3):303-306. doi: 10.1007/s10517-026-06625-w. Epub 2026 Apr 7.

Preclinical Catecholaminergic Biomarkers of Central Lewy Body Diseases

Goldstein DS.

J Clin Neurol. 2026 Jan;22(1):6-16. doi: 10.3988/jcn.2025.0629.

Nature-origin phthalides for Parkinson's disease drug development

Vinayagam J, Kalaivani D, Senthilkumar GP.

Neurochem Int. 2026 May 13;197:106181. doi: 10.1016/j.neuint.2026.106181. Online ahead of print.

Intensive Conventional Rehabilitation for Reducing Upper Limb Co-contraction and Functional Improvement in Parkinson's Disease: A Case Report

Kyota B, Sano T, Miyazaki Y, Takao M, Hara T.

Cureus. 2026 Jan 2;18(1):e100647. doi: 10.7759/cureus.100647. eCollection 2026 Jan.

Resolution of Visual Hallucinations in Parkinson's Disease After Right Occipitoparietal Subcortical Hemorrhage: A Case Report

Nishijima H, Shibuya E, Seino S, Mikami Y, Tomiyama M.

Cureus. 2026 Feb 9;18(2):e103306. doi: 10.7759/cureus.103306. eCollection 2026 Feb.

Chronic nicotine reduces nigral dopaminergic activity and remodels pedunculopontine cholinergic subpopulations

Chen RY, Hosseini H, Hall S, Zhang S, Evans R.

bioRxiv [Preprint]. 2026 Feb 13:2026.02.12.705607. doi: 10.64898/2026.02.12.705607.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias